
### [MONDO:0019280](http://purl.obolibrary.org/obo/MONDO_0019280)
**Label:** hypertrichosis (disease)

**Subclasses:** [MONDO:0018777](http://purl.obolibrary.org/obo/MONDO_0018777) (autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome), [MONDO:0019940](http://purl.obolibrary.org/obo/MONDO_0019940) (hypertrichosis-acromegaloid facial appearance syndrome), [MONDO:0008894](http://purl.obolibrary.org/obo/MONDO_0008894) (cataract-hypertrichosis-intellectual disability syndrome), [MONDO:0016381](http://purl.obolibrary.org/obo/MONDO_0016381) (hypertrichosis lanuginosa congenita), [MONDO:0009874](http://purl.obolibrary.org/obo/MONDO_0009874) (Rabson-Mendenhall syndrome), [MONDO:0008853](http://purl.obolibrary.org/obo/MONDO_0008853) (Barber-Say syndrome), [MONDO:0001334](http://purl.obolibrary.org/obo/MONDO_0001334) (hypertrichosis of eyelid), [MONDO:0009405](http://purl.obolibrary.org/obo/MONDO_0009405) (cervical hypertrichosis-peripheral neuropathy syndrome), [MONDO:0016380](http://purl.obolibrary.org/obo/MONDO_0016380) (acquired hypertrichosis lanuginosa), [MONDO:0009517](http://purl.obolibrary.org/obo/MONDO_0009517) (Donohue syndrome), [MONDO:0007787](http://purl.obolibrary.org/obo/MONDO_0007787) (Ambras type hypertrichosis universalis congenita), [MONDO:0007610](http://purl.obolibrary.org/obo/MONDO_0007610) (gingival fibromatosis-hypertrichosis syndrome), [MONDO:0007693](http://purl.obolibrary.org/obo/MONDO_0007693) (hypertrichosis cubiti-short stature syndrome), [MONDO:0010614](http://purl.obolibrary.org/obo/MONDO_0010614) (X-linked congenital generalized hypertrichosis), [MONDO:0010887](http://purl.obolibrary.org/obo/MONDO_0010887) (isolated anterior cervical hypertrichosis), 

**Mapped go classes:** [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0043392](http://purl.obolibrary.org/obo/GO_0043392) (negative regulation of DNA binding), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0031981](http://purl.obolibrary.org/obo/GO_0031981) (nuclear lumen), [GO:0044092](http://purl.obolibrary.org/obo/GO_0044092) (negative regulation of molecular function), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0010838](http://purl.obolibrary.org/obo/GO_0010838) (positive regulation of keratinocyte proliferation), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), 

**Class expressions from DL-Learner:**

- [GO:1903556](http://purl.obolibrary.org/obo/GO_1903556) (negative regulation of tumor necrosis factor superfamily cytokine production) 54.17%
- [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex) 54.17%
- [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis) 54.17%
- [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis) 54.17%
- [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis) 54.17%
- [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis) 54.17%
- [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation) 54.17%
- [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production) 54.17%
- [GO:0031981](http://purl.obolibrary.org/obo/GO_0031981) (nuclear lumen) 54.17%
- [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus) 54.17%
- [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope) 54.17%
- [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation) 54.17%
- [GO:0045667](http://purl.obolibrary.org/obo/GO_0045667) (regulation of osteoblast differentiation) and [GO:0051093](http://purl.obolibrary.org/obo/GO_0051093) (negative regulation of developmental process) 54.17%
- [GO:0045667](http://purl.obolibrary.org/obo/GO_0045667) (regulation of osteoblast differentiation) and [GO:0048523](http://purl.obolibrary.org/obo/GO_0048523) (negative regulation of cellular process) 54.17%
- [GO:0045667](http://purl.obolibrary.org/obo/GO_0045667) (regulation of osteoblast differentiation) and [GO:0048519](http://purl.obolibrary.org/obo/GO_0048519) (negative regulation of biological process) 54.17%


